G. Ubeaud

882 total citations
20 papers, 770 citations indexed

About

G. Ubeaud is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, G. Ubeaud has authored 20 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 7 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in G. Ubeaud's work include Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (6 papers) and Free Radicals and Antioxidants (4 papers). G. Ubeaud is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (6 papers) and Free Radicals and Antioxidants (4 papers). G. Ubeaud collaborates with scholars based in France, Switzerland and Bulgaria. G. Ubeaud's co-authors include Louis Jung, Christophe Schmitt, Ruby C. Chou, D Jaeck, Ph. Coassolo, Thierry Lavé, Sylvie Dupin, Philippe Coassolo, Daniel Jaeck and Abraham Al Ahmad and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Life Sciences and Pharmaceutical Research.

In The Last Decade

G. Ubeaud

20 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Ubeaud France 11 259 221 200 155 130 20 770
F.A.A. van Acker Netherlands 11 171 0.7× 196 0.9× 282 1.4× 107 0.7× 102 0.8× 13 830
Pei-Dawn Lee Chao Taiwan 10 215 0.8× 119 0.5× 362 1.8× 163 1.1× 51 0.4× 12 952
Marie‐Hélène Siess France 16 248 1.0× 221 1.0× 391 2.0× 423 2.7× 78 0.6× 21 1.1k
D. Sakthisekaran India 22 420 1.6× 152 0.7× 488 2.4× 296 1.9× 116 0.9× 45 1.4k
Yoko Otake United States 12 265 1.0× 287 1.3× 615 3.1× 167 1.1× 183 1.4× 18 1.2k
Kaustubh H. Kulkarni United States 12 204 0.8× 107 0.5× 346 1.7× 97 0.6× 137 1.1× 18 945
Narumi Sugihara Japan 15 97 0.4× 303 1.4× 259 1.3× 134 0.9× 101 0.8× 48 905
Jun-Yan Hong United States 14 336 1.3× 135 0.6× 325 1.6× 215 1.4× 143 1.1× 15 951
Manasi Deshpande India 5 129 0.5× 103 0.5× 437 2.2× 164 1.1× 84 0.6× 17 975
Chinnadurai Veeramani Saudi Arabia 16 230 0.9× 169 0.8× 272 1.4× 211 1.4× 55 0.4× 43 1.1k

Countries citing papers authored by G. Ubeaud

Since Specialization
Citations

This map shows the geographic impact of G. Ubeaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Ubeaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Ubeaud more than expected).

Fields of papers citing papers by G. Ubeaud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Ubeaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Ubeaud. The network helps show where G. Ubeaud may publish in the future.

Co-authorship network of co-authors of G. Ubeaud

This figure shows the co-authorship network connecting the top 25 collaborators of G. Ubeaud. A scholar is included among the top collaborators of G. Ubeaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Ubeaud. G. Ubeaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ahmad, Abraham Al, et al.. (2009). Quercetin and naringenin transport across human intestinal Caco-2 cells. Journal of Pharmacy and Pharmacology. 61(11). 1473–1483. 46 indexed citations
2.
Ahmad, Abraham Al, et al.. (2007). Transport of quercetin di-sodium salt in the human intestinal epithelial Caco-2 cell monolayer 139. European Journal of Drug Metabolism and Pharmacokinetics. 32(3). 139–147. 2 indexed citations
3.
Vandamme, Thierry, et al.. (2005). Free radical scavenging activity of hydroxyflavone sodium salts compared to the activity of hydroxyflavones themselves. Croatica Chemica Acta. 78(1). 35–41. 2 indexed citations
4.
Ubeaud, G., et al.. (2004). Isolation of quercetin's salts and studies of their physicochemical properties and antioxidant relationships. Bioorganic & Medicinal Chemistry. 12(13). 3627–3635. 15 indexed citations
5.
Hérin, Michel, et al.. (2004). Inhibition of in-vitro simvastatin metabolism in rat liver microsomes by bergamottin, a component of grapefruit juice. Journal of Pharmacy and Pharmacology. 56(8). 1007–1014. 7 indexed citations
6.
Jung, Louis, et al.. (2003). In vitro inhibition of simvastatin metabolism, a HMG-CoA reductase inhibitor in human and rat liver by bergamottin, a component of grapefruit juice. European Journal of Pharmaceutical Sciences. 18(1). 31–35. 22 indexed citations
7.
Ubeaud, G., et al.. (2003). Anti- and pro-oxidant activity of rutin and quercetin derivatives. Journal of Pharmacy and Pharmacology. 55(1). 131–142. 367 indexed citations
8.
Jung, Louis, et al.. (2002). Comparison of in vitro hepatic models for the prediction of metabolic interaction between simvastatin and naringenin. European Journal of Drug Metabolism and Pharmacokinetics. 27(4). 233–241. 5 indexed citations
9.
Ubeaud, G., et al.. (2002). Free radical scavenging and skin penetration of troxerutin and vitamin derivatives. Journal of Dermatological Treatment. 13(3). 133–141. 36 indexed citations
10.
Ubeaud, G., et al.. (2001). Comparison of the stability of some major cytochrome P450 and conjugation reactions in rat, dog and human hepatocyte monolayers. European Journal of Drug Metabolism and Pharmacokinetics. 26(1-2). 37–45. 9 indexed citations
11.
Ubeaud, G., et al.. (1999). In vitro inhibition of simvastatin metabolism in rat and human liver by naringenin. Life Sciences. 65(13). 1403–1412. 34 indexed citations
12.
Ubeaud, G., et al.. (1999). Estimation of flavin-containing monooxygenase activity in intact hepatocyte monolayers of rat, hamster, rabbit, dog and human by using N-oxidation of benzydamine. European Journal of Pharmaceutical Sciences. 8(4). 255–260. 15 indexed citations
13.
Ubeaud, G., et al.. (1998). Concentrations of Pefloxacin in Plasma and Tissue after Administration as Surgical Prophylaxis. Antimicrobial Agents and Chemotherapy. 42(2). 425–427. 1 indexed citations
14.
Vickers, Alison E.M., et al.. (1998). In vitro biotransformation of SDZ RAD: a new immunosuppressive macrolide in human liver microsomal preparations. Transplantation Proceedings. 30(5). 2206–2206. 4 indexed citations
15.
Dupin, Sylvie, Christophe Schmitt, G. Ubeaud, et al.. (1997). The Use of Human Hepatocytes to Select Compounds Based on Their Expected Hepatic Extraction Ratios in Humans. Pharmaceutical Research. 14(2). 152–155. 88 indexed citations
16.
Lavé, Thierry, Philippe Coassolo, G. Ubeaud, et al.. (1996). Interspecies Scaling of Bosentan, A New Endothelin Receptor Antagonist and Integration of in Vitro Data into Allometric Scaling. Pharmaceutical Research. 13(1). 97–101. 38 indexed citations
17.
Lavé, Thierry, Anne Schmitt‐Hoffmann, Philippe Coassolo, et al.. (1995). A new extrapolation method from animals to man: Application to a metabolized compound, mofarotene. Life Sciences. 56(26). 473–478. 34 indexed citations
18.
Ubeaud, G., Christophe Schmitt, D Jaeck, Thierry Lavé, & Ph. Coassolo. (1995). Bosentan, a new endothelin receptor antagonist: prediction of the systemic plasma clearance in man from combined in vivo and in vitro data. Xenobiotica. 25(12). 1381–1390. 41 indexed citations
19.
Ubeaud, G., et al.. (1994). Calcium Anti-Ionophoretic Effect of Some Calcium Channel Blockers in Rat Liver Mitochondria. Journal of Pharmaceutical Sciences. 83(2). 165–168. 1 indexed citations
20.
Ubeaud, G., et al.. (1991). Counteraction by nicardipine of the ionophoretic effect of gliclazide: A mitochondrial study. Pharmacological Research. 24(1). 33–40. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F.A.A. van Acker Breakdown of academic impact, for papers by Pei-Dawn Lee Chao Breakdown of academic impact, for papers by Marie‐Hélène Siess Breakdown of academic impact, for papers by D. Sakthisekaran Breakdown of academic impact, for papers by Yoko Otake Breakdown of academic impact, for papers by Kaustubh H. Kulkarni Breakdown of academic impact, for papers by Narumi Sugihara Breakdown of academic impact, for papers by Jun-Yan Hong Breakdown of academic impact, for papers by Manasi Deshpande Breakdown of academic impact, for papers by Chinnadurai Veeramani
Rankless by CCL
2026